OMK1

Medical device - ophthalmic solution containing 2% citicoline and 0,2% high molecular weight hyaluronic acid.

• Due to the presence of citicoline, it offers structural support in restoring the integrity of cell membranes affected by ocular degenerative processes, such as glaucoma.
• Solutions containing hyaluronic acid also make it possible to provide a suitable microenvironment for regenerative processes on the surface of the eye in the event of damage to the corneal and conjunctival epithelium.
• Hyaluronic acid, which is obtained by biotechnological production and gives the solution mucomimetic, mucoadhesive and viscoelastic properties, which are useful for increasing the stability of the tear film, moisturizes the surface of the eye, which remains lubricated, hydrated and protected.
• The preparation contains 0,01% benzalkonium chloride.

Preparation:

• is used as an adjunct to treatment to reduce intraocular pressure in patients with glaucoma,
• provides relief to the eyes from irritation, burning, and foreign body sensation in the eye caused by environmental factors, eye / eye surgery, or conjunctivitis.